"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","29/44","481/2914",1.9471027837073e-13,9.83286905772185e-11,6.16924145153575e-11,"CSNK2A1/RB1/CTNNB1/SMAD2/SMAD3/MAPK3/MAPK14/EGFR/CREB1/NR0B2/VDR/TCF7/PRKAA1/CSNK2A2/PCGF2/CDK5/PPARG/CDK2/UBE2I/STK11/AKT1/EP300/HDAC1/ATM/CHEK2/MAPK1/GSK3B/MYB/ASH2L",29
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","29/44","499/2914",5.24121106103042e-13,1.32340579291018e-10,8.30318173352713e-11,"CSNK2A1/RB1/CTNNB1/SMAD2/SMAD3/MAPK3/MAPK14/EGFR/CREB1/NR0B2/VDR/TCF7/PRKAA1/CSNK2A2/PCGF2/CDK5/PPARG/CDK2/UBE2I/STK11/AKT1/EP300/HDAC1/ATM/CHEK2/MAPK1/GSK3B/MYB/ASH2L",29
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","24/44","397/2914",1.12767821992099e-10,1.898258336867e-08,1.19098647086392e-08,"CSNK2A1/CTNNB1/SMAD2/SMAD3/MAPK3/MAPK14/EGFR/CREB1/CSNK2A2/RPS6KA5/PCGF2/CDK5/PPARG/CDK2/STX1A/AKT1/PAX6/EP300/STAT3/MAPK1/GSK3B/MYB/ASH2L/RPS6KA4",24
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","12/44","95/2914",6.38765171687307e-09,8.06441029255225e-07,5.05969254415472e-07,"CSNK2A1/MAPK14/PRKAA1/CSNK2A2/CDK5/CDK2/STK11/AKT1/EP300/HDAC1/ATM/CHEK2",12
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","7/44","23/2914",2.23417740324378e-08,2.25651917727622e-06,1.41576294395027e-06,"MAPK3/DUSP10/DUSP8/DUSP2/MAPK1/DUSP7/DUSP9",7
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","9/44","56/2914",7.7839966638287e-08,6.55153052538916e-06,4.11049648388147e-06,"CSNK2A1/MAPK14/PRKAA1/CSNK2A2/CDK5/CDK2/STK11/ATM/CHEK2",9
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","7/44","34/2914",4.33296120026237e-07,3.12592200876071e-05,1.96123506959244e-05,"MAPK3/DUSP10/DUSP8/DUSP2/MAPK1/DUSP7/DUSP9",7
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","6/44","24/2914",9.16879578483167e-07,5.78780233917499e-05,3.63132569899254e-05,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","10/44","108/2914",2.7787832173336e-06,0.000155920613861497,9.78261694055455e-05,"CSNK2A1/CTNNB1/TCF7/CSNK2A2/SOX6/AKT1/EP300/HDAC1/GSK3B/ASH2L",10
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","6/44","30/2914",3.78021388259693e-06,0.000190900801071145,0.000119773092490703,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","6/44","31/2914",4.63489179673121e-06,0.000212783668849933,0.000133502624958478,"CTNNB1/TCF7/SOX6/AKT1/HDAC1/ASH2L",6
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","5/44","20/2914",8.15320700249646e-06,0.000332924111842015,0.000208879953443349,"CSNK2A1/MAPK3/EGFR/CSNK2A2/MAPK1",5
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","14/44","249/2914",8.57032367118058e-06,0.000332924111842015,0.000208879953443349,"CSNK2A1/RB1/MAPK3/CSNK2A2/CDK2/UBE2I/AKT1/EP300/HDAC1/ATM/CHEK2/CSNK1D/MAPK1/GSK3B",14
"R-HSA-373760","R-HSA-373760","L1CAM interactions","7/44","53/2914",1.00265092465533e-05,0.000356247006001024,0.000223512973019923,"CSNK2A1/MAPK3/EGFR/CSNK2A2/RPS6KA5/MAPK1/RPS6KA4",7
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","5/44","21/2914",1.05815942376542e-05,0.000356247006001024,0.000223512973019923,"MAPK3/MAPK14/RPS6KA5/MAPK1/DUSP7",5
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","5/44","22/2914",1.35409273246582e-05,0.000427385518684523,0.000268145995047507,"CTNNB1/TCF7/EP300/HDAC1/ASH2L",5
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","12/44","194/2914",1.71889982115126e-05,0.00051061435863611,0.00032036461062943,"CSNK2A1/MAPK14/PRKAA1/CSNK2A2/CDK5/CDK2/STK11/AKT1/EP300/HDAC1/ATM/CHEK2",12
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","7/44","59/2914",2.07407103413266e-05,0.000567998157662217,0.000356367786256024,"CSNK2A1/MAPK3/CSNK2A2/PPARG/AKT1/HDAC1/MAPK1",7
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","5/44","24/2914",2.1370227714024e-05,0.000567998157662217,0.000356367786256024,"MAPK3/EGFR/CREB1/AKT1/MAPK1",5
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","5/44","27/2914",3.92453085170263e-05,0.000955664379762601,0.000599593493087114,"CREB1/CDK2/EP300/STAT3/MYB",5
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","8/44","89/2914",3.9740498960425e-05,0.000955664379762601,0.000599593493087114,"MAPK3/MAPK14/CREB1/RPS6KA5/CDK5/STAT3/MAPK1/DUSP7",8
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","7/44","70/2914",6.4382596057108e-05,0.00147787322767452,0.00092723260350189,"MAPK3/MAPK14/CREB1/RPS6KA5/STAT3/MAPK1/DUSP7",7
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","6/44","49/2914",7.18478215761408e-05,0.0015775282563457,0.000989757175945921,"SMAD2/SMAD3/STK11/AKT1/EP300/HDAC1",6
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","11/44","191/2914",8.14581587667656e-05,0.00171401542405069,0.00107539060477177,"CSNK2A1/RB1/MAPK3/CSNK2A2/CDK2/AKT1/EP300/HDAC1/CSNK1D/MAPK1/GSK3B",11
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","4/44","18/2914",0.000118703144204776,0.00239780351293647,0.0015044061644479,"MAPK3/EGFR/CREB1/MAPK1",4
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","11/44","201/2914",0.000129920848464799,0.0025234626336432,0.00158324596712163,"CSNK2A1/MAPK3/EGFR/CREB1/CSNK2A2/PPARG/AKT1/CAMKK2/HDAC1/MAPK1/GSK3B",11
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","8/44","108/2914",0.000160028196498702,0.00295589461835999,0.00185455816597469,"MAPK3/EGFR/CREB1/AKT1/EP300/HDAC1/MAPK1/MYB",8
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","10/44","172/2914",0.000169744443430574,0.00295589461835999,0.00185455816597469,"CSNK2A1/MAPK3/EGFR/CREB1/CSNK2A2/PPARG/AKT1/HDAC1/MAPK1/GSK3B",10
"R-HSA-195721","R-HSA-195721","Signaling by WNT","10/44","172/2914",0.000169744443430574,0.00295589461835999,0.00185455816597469,"CSNK2A1/CTNNB1/TCF7/CSNK2A2/SOX6/AKT1/EP300/HDAC1/GSK3B/ASH2L",10
"R-HSA-450294","R-HSA-450294","MAP kinase activation","6/44","60/2914",0.000227185232255873,0.00382428474297386,0.00239939490908834,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","4/44","23/2914",0.000325081141955831,0.00513209301377786,0.00321992703938955,"PCGF2/UBE2I/PIAS1/HDAC1",4
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","6/44","64/2914",0.00032520193354632,0.00513209301377786,0.00321992703938955,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/44","10/2914",0.000358169961705094,0.00548108577760826,0.00343888862753536,"MAPK3/MAPK14/MAPK1",3
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","12/44","268/2914",0.000411299815484657,0.00610901196528682,0.00383285586566197,"CTNNB1/SMAD2/SMAD3/MAPK3/EGFR/CREB1/AKT1/EP300/HDAC1/STAT3/MAPK1/GSK3B",12
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","7/44","99/2914",0.000576260340564047,0.00819324675864514,0.0051405258454449,"RB1/MAPK3/MAPK14/CDK2/ATM/STAT3/MAPK1",7
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","5/44","47/2914",0.000595821658012219,0.00819324675864514,0.0051405258454449,"MAPK3/CREB1/PRKAA1/CAMKK2/MAPK1",5
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","4/44","27/2914",0.000616521538274288,0.00819324675864514,0.0051405258454449,"PCGF2/PAX6/EP300/ASH2L",4
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","4/44","27/2914",0.000616521538274288,0.00819324675864514,0.0051405258454449,"PCGF2/PAX6/EP300/ASH2L",4
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/44","12/2914",0.000642891338781762,0.00832461861755872,0.00522294987782214,"MAPK3/MAPK1/DUSP7",3
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","4/44","28/2914",0.000711401195711012,0.00870838150620428,0.0054637265937832,"VDR/PPARG/UBE2I/PIAS1",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","5/44","49/2914",0.000724261432199168,0.00870838150620428,0.0054637265937832,"MAPK3/EP300/ATM/MAPK1/GSK3B",5
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","5/44","49/2914",0.000724261432199168,0.00870838150620428,0.0054637265937832,"MAPK3/CREB1/PRKAA1/CAMKK2/MAPK1",5
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","8/44","136/2914",0.00078046014692841,0.00907864726542262,0.00569603507429329,"MAPK3/EGFR/CREB1/AKT1/EP300/HDAC1/MAPK1/MYB",8
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","4/44","29/2914",0.000816193574668981,0.00907864726542262,0.00569603507429329,"CDK2/AKT1/ATM/CHEK2",4
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","4/44","29/2914",0.000816193574668981,0.00907864726542262,0.00569603507429329,"CDK2/AKT1/ATM/CHEK2",4
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","3/44","13/2914",0.000826965889523644,0.00907864726542262,0.00569603507429329,"EP300/ATM/CHEK2",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","7/44","107/2914",0.000922060871899681,0.00960680903611423,0.00602740910864072,"VDR/PCGF2/PPARG/UBE2I/EP300/PIAS1/HDAC1",7
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","6/44","78/2914",0.000951169211496459,0.00960680903611423,0.00602740910864072,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","6/44","78/2914",0.000951169211496459,0.00960680903611423,0.00602740910864072,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","6/44","78/2914",0.000951169211496459,0.00960680903611423,0.00602740910864072,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-422475","R-HSA-422475","Axon guidance","11/44","254/2914",0.00100888831821005,0.00992309752422981,0.00622585170358139,"CSNK2A1/MAPK3/MAPK14/EGFR/CREB1/CSNK2A2/RPS6KA5/CDK5/MAPK1/GSK3B/RPS6KA4",11
"R-HSA-2990846","R-HSA-2990846","SUMOylation","7/44","109/2914",0.00103005850386173,0.00992309752422981,0.00622585170358139,"VDR/PCGF2/PPARG/UBE2I/EP300/PIAS1/HDAC1",7
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","3/44","14/2914",0.00104143399759244,0.00992309752422981,0.00622585170358139,"AKT1/EP300/HDAC1",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","4/44","32/2914",0.00119563625505249,0.0107820769428841,0.00676478407463911,"MAPK3/ATM/MAPK1/GSK3B",4
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","4/44","32/2914",0.00119563625505249,0.0107820769428841,0.00676478407463911,"MAPK3/CREB1/RPS6KA5/MAPK1",4
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/44","32/2914",0.00119563625505249,0.0107820769428841,0.00676478407463911,"MAPK3/PPARG/HDAC1/MAPK1",4
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","3/44","15/2914",0.00128810929913156,0.0114121964221305,0.0071601274060683,"EP300/HDAC1/GSK3B",3
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","6/44","83/2914",0.00132100998488802,0.0115018972822147,0.00721640663250989,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","6/44","84/2914",0.00140664856395742,0.0118392920799749,0.00742809153949445,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","6/44","84/2914",0.00140664856395742,0.0118392920799749,0.00742809153949445,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","9/44","187/2914",0.00151452293574915,0.0121709076962106,0.0076361505295662,"RB1/MAPK3/MAPK14/CDK2/EP300/ATM/STAT3/MAPK1/GSK3B",9
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/44","16/2914",0.0015687092454521,0.0121709076962106,0.0076361505295662,"MAPK3/MAPK14/MAPK1",3
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","6/44","86/2914",0.0015906532830691,0.0121709076962106,0.0076361505295662,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","6/44","86/2914",0.0015906532830691,0.0121709076962106,0.0076361505295662,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","6/44","86/2914",0.0015906532830691,0.0121709076962106,0.0076361505295662,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","6/44","86/2914",0.0015906532830691,0.0121709076962106,0.0076361505295662,"CSNK2A1/CSNK2A2/EP300/HDAC1/MYB/ASH2L",6
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","9/44","189/2914",0.00163303065656936,0.012187030669388,0.00764626624593181,"RB1/MAPK3/MAPK14/CDK2/EP300/ATM/STAT3/MAPK1/GSK3B",9
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","6/44","87/2914",0.00168929137991517,0.012187030669388,0.00764626624593181,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","6/44","87/2914",0.00168929137991517,0.012187030669388,0.00764626624593181,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","6/44","87/2914",0.00168929137991517,0.012187030669388,0.00764626624593181,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","6/44","88/2914",0.0017925372741796,0.0127497369501507,0.00799931385512321,"MAPK3/CREB1/PRKAA1/STX1A/CAMKK2/MAPK1",6
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","6/44","90/2914",0.00201341352097077,0.0139284086039758,0.00873882436643404,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","6/44","90/2914",0.00201341352097077,0.0139284086039758,0.00873882436643404,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","4/44","37/2914",0.00207852155579172,0.0139953784756643,0.00878084194095871,"CTNNB1/TCF7/HDAC1/GSK3B",4
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","4/44","37/2914",0.00207852155579172,0.0139953784756643,0.00878084194095871,"PCGF2/UBE2I/EP300/PIAS1",4
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","5/44","62/2914",0.00212466640451659,0.0141178491352747,0.00885768127090711,"RB1/MAPK3/AKT1/MAPK1/GSK3B",5
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","3/44","18/2914",0.00223808889652689,0.0146783752304686,0.00920936100963219,"CSNK2A1/CSNK2A2/EP300",3
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","5/44","63/2914",0.00228213238712984,0.0147753443012894,0.00927020038496737,"MAPK3/EGFR/CREB1/AKT1/MAPK1",5
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/44","19/2914",0.00262984776584317,0.016600914021885,0.010415581283142,"RB1/MAPK3/MAPK1",3
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/44","19/2914",0.00262984776584317,0.016600914021885,0.010415581283142,"SMAD2/SMAD3/HDAC1",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/44","20/2914",0.0030614949556744,0.0186271681038021,0.0116868735784146,"SMAD2/SMAD3/HDAC1",3
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","3/44","20/2914",0.0030614949556744,0.0186271681038021,0.0116868735784146,"RPS6KA5/MAPK1/RPS6KA4",3
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","3/44","20/2914",0.0030614949556744,0.0186271681038021,0.0116868735784146,"EP300/HDAC1/ASH2L",3
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","8/44","171/2914",0.00342853259427251,0.0206120114298526,0.0129321843468174,"MAPK3/EGFR/DUSP10/DUSP8/DUSP2/MAPK1/DUSP7/DUSP9",8
"R-HSA-1500620","R-HSA-1500620","Meiosis","3/44","22/2914",0.00404948518468357,0.0231920991548718,0.0145509574687158,"CDK2/UBE2I/ATM",3
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/44","22/2914",0.00404948518468357,0.0231920991548718,0.0145509574687158,"MAPK3/CREB1/MAPK1",3
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","3/44","22/2914",0.00404948518468357,0.0231920991548718,0.0145509574687158,"CDK2/ATM/CHEK2",3
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","3/44","22/2914",0.00404948518468357,0.0231920991548718,0.0145509574687158,"CDK2/ATM/CHEK2",3
"R-HSA-1643685","R-HSA-1643685","Disease","14/44","443/2914",0.00408732044511602,0.0231920991548718,0.0145509574687158,"CTNNB1/SMAD2/SMAD3/MAPK3/EGFR/CREB1/CDK5/STX1A/AKT1/EP300/HDAC1/STAT3/MAPK1/GSK3B",14
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/44","104/2914",0.00418928685559821,0.0235065540230789,0.014748249631989,"SMAD3/EGFR/CREB1/AKT1/EP300/HDAC1",6
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","8/44","177/2914",0.00424510708360931,0.0235580118376121,0.0147805347850365,"MAPK3/EGFR/DUSP10/DUSP8/DUSP2/MAPK1/DUSP7/DUSP9",8
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/44","45/2914",0.00429498143999032,0.0235757133390773,0.0147916408860079,"MAPK3/CDK2/STAT3/MAPK1",4
"R-HSA-112316","R-HSA-112316","Neuronal System","6/44","105/2914",0.00439328926942368,0.0236022455431804,0.0148082874590876,"MAPK3/CREB1/PRKAA1/STX1A/CAMKK2/MAPK1",6
"R-HSA-68886","R-HSA-68886","M Phase","6/44","105/2914",0.00439328926942368,0.0236022455431804,0.0148082874590876,"CSNK2A1/RB1/MAPK3/CSNK2A2/CSNK1D/MAPK1",6
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/44","23/2914",0.00460814579109273,0.024495932889493,0.0153689959348356,"RB1/MAPK3/MAPK1",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","4/44","47/2914",0.0050301357849633,0.0250640383904606,0.0157254310693666,"EGFR/CDK2/AKT1/STAT3",4
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","4/44","47/2914",0.0050301357849633,0.0250640383904606,0.0157254310693666,"EGFR/CDK2/AKT1/STAT3",4
"R-HSA-1474165","R-HSA-1474165","Reproduction","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"CDK2/UBE2I/ATM",3
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"AKT1/PAX6/EP300",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"SMAD2/SMAD3/HDAC1",3
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"RB1/CDK2/ATM",3
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"CREB1/AKT1/GSK3B",3
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"CDK2/ATM/CHEK2",3
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"RB1/MAPK3/MAPK1",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/44","24/2914",0.00521133471484823,0.0250640383904606,0.0157254310693666,"MAPK3/STAT3/MAPK1",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","5/44","77/2914",0.00548495513717359,0.0260805835390378,0.016363221772278,"MAPK3/CREB1/PRKAA1/CAMKK2/MAPK1",5
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","6/44","110/2914",0.00552598502708325,0.0260805835390378,0.016363221772278,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/44","49/2914",0.00584570827558992,0.0269028360898914,0.0168791113351898,"MAPK3/AKT1/STAT3/MAPK1",4
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","3/44","25/2914",0.00586002370274862,0.0269028360898914,0.0168791113351898,"EGFR/UBE2I/EP300",3
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","3/44","25/2914",0.00586002370274862,0.0269028360898914,0.0168791113351898,"CSNK2A1/CSNK2A2/AKT1",3
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","8/44","188/2914",0.00612826480733836,0.0278808443937466,0.017492723632137,"MAPK3/EGFR/DUSP10/DUSP8/DUSP2/MAPK1/DUSP7/DUSP9",8
"R-HSA-111996","R-HSA-111996","Ca-dependent events","3/44","26/2914",0.00655511386390725,0.0295565401899389,0.0185440721150008,"CREB1/CAMKK2/MAPK1",3
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","5/44","81/2914",0.006801812279419,0.0303974796558106,0.019071686037309,"CDK2/UBE2I/ATM/CHEK2/PRKDC",5
"R-HSA-165159","R-HSA-165159","mTOR signalling","3/44","27/2914",0.00729743790461137,0.0323263696651644,0.0202818911291599,"PRKAA1/STK11/AKT1",3
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","4/44","53/2914",0.00773301587805324,0.0339580262471033,0.0213056089637897,"CTNNB1/SMAD3/TCF7/EP300",4
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","6/44","119/2914",0.00808786702829485,0.0352101107697319,0.0220911794511502,"CSNK2A1/VDR/CSNK2A2/PPARG/UBE2I/EP300",6
"R-HSA-73894","R-HSA-73894","DNA Repair","7/44","157/2914",0.00817478363890508,0.035284322543992,0.0221377406685599,"CDK2/UBE2I/EP300/PIAS1/ATM/CHEK2/PRKDC",7
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/44","10/2914",0.00928642537501833,0.0381271936128801,0.023921386716992,"MAPK3/MAPK1",2
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","2/44","10/2914",0.00928642537501833,0.0381271936128801,0.023921386716992,"CREB1/CAMKK2",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/44","10/2914",0.00928642537501833,0.0381271936128801,0.023921386716992,"EP300/GSK3B",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/44","10/2914",0.00928642537501833,0.0381271936128801,0.023921386716992,"MAPK3/MAPK1",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/44","10/2914",0.00928642537501833,0.0381271936128801,0.023921386716992,"CSNK2A1/CSNK2A2",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/44","10/2914",0.00928642537501833,0.0381271936128801,0.023921386716992,"MAPK3/MAPK1",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","8/44","202/2914",0.00938598057702935,0.0382251628338695,0.0239828535966539,"MAPK3/EGFR/DUSP10/DUSP8/DUSP2/MAPK1/DUSP7/DUSP9",8
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/44","30/2914",0.0098151597672071,0.0396532454595167,0.0248788470730891,"CSNK2A1/CSNK2A2/STAT3",3
"R-HSA-391251","R-HSA-391251","Protein folding","3/44","31/2914",0.0107534535869071,0.0430991592173658,0.0270408482009945,"CSNK2A1/CSNK2A2/STAT3",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","6/44","127/2914",0.011008146443869,0.0433918880795848,0.0272245092484732,"MAPK3/MAPK14/CREB1/RPS6KA5/MAPK1/DUSP7",6
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","2/44","11/2914",0.0112417870977687,0.0433918880795848,0.0272245092484732,"AKT1/PAX6",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/44","11/2914",0.0112417870977687,0.0433918880795848,0.0272245092484732,"CREB1/EP300",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/44","11/2914",0.0112417870977687,0.0433918880795848,0.0272245092484732,"SMAD2/STAT3",2
"R-HSA-111885","R-HSA-111885","Opioid Signalling","4/44","59/2914",0.0112561135414369,0.0433918880795848,0.0272245092484732,"CREB1/CDK5/CAMKK2/MAPK1",4
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","11/44","347/2914",0.0117179111495887,0.0448298873525933,0.0281267245297146,"CTNNB1/MAPK3/MAPK14/EGFR/CREB1/RPS6KA5/CDK5/AKT1/STAT3/MAPK1/DUSP7",11
"R-HSA-69206","R-HSA-69206","G1/S Transition","4/44","60/2914",0.0119291339877916,0.045294832058908,0.0284184355387833,"RB1/CDK2/AKT1/HDAC1",4
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/44","33/2914",0.0127818452399566,0.0471859507414747,0.0296049425183614,"MAPK3/MAPK14/MAPK1",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/44","33/2914",0.0127818452399566,0.0471859507414747,0.0296049425183614,"RB1/MAPK3/MAPK1",3
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/44","62/2914",0.0133519909648414,0.0471859507414747,0.0296049425183614,"CDK5/CDK2/HDAC1/MYB",4
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/44","12/2914",0.0133615662495661,0.0471859507414747,0.0296049425183614,"MAPK3/MAPK1",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","2/44","12/2914",0.0133615662495661,0.0471859507414747,0.0296049425183614,"CREB1/CAMKK2",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","2/44","12/2914",0.0133615662495661,0.0471859507414747,0.0296049425183614,"CSNK2A1/CSNK2A2",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/44","12/2914",0.0133615662495661,0.0471859507414747,0.0296049425183614,"SMAD2/SMAD3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/44","12/2914",0.0133615662495661,0.0471859507414747,0.0296049425183614,"MAPK3/MAPK1",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/44","12/2914",0.0133615662495661,0.0471859507414747,0.0296049425183614,"CTNNB1/PAX6",2
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","2/44","12/2914",0.0133615662495661,0.0471859507414747,0.0296049425183614,"CREB1/HDAC1",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","3/44","34/2914",0.0138728214779556,0.0476583322882149,0.0299013194762954,"CREB1/CAMKK2/MAPK1",3
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","3/44","34/2914",0.0138728214779556,0.0476583322882149,0.0299013194762954,"CREB1/CAMKK2/MAPK1",3
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","3/44","34/2914",0.0138728214779556,0.0476583322882149,0.0299013194762954,"CTNNB1/EP300/PRKDC",3
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3/44","34/2914",0.0138728214779556,0.0476583322882149,0.0299013194762954,"UBE2I/ATM/CHEK2",3
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","3/44","35/2914",0.0150154817682018,0.0512352587360941,0.0321455192903894,"UBE2I/ATM/CHEK2",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/44","13/2914",0.0156405844968466,0.0519637840191285,0.032602603417942,"MAPK3/MAPK1",2
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","2/44","13/2914",0.0156405844968466,0.0519637840191285,0.032602603417942,"AKT1/GSK3B",2
"R-HSA-912446","R-HSA-912446","Meiotic recombination","2/44","13/2914",0.0156405844968466,0.0519637840191285,0.032602603417942,"CDK2/ATM",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/44","13/2914",0.0156405844968466,0.0519637840191285,0.032602603417942,"STK11/EP300",2
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/44","36/2914",0.016210135284576,0.0535040412987639,0.0335689764063115,"SMAD2/SMAD3/HDAC1",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/44","101/2914",0.0168214048098003,0.0551611001879814,0.0346086319053307,"CTNNB1/MAPK3/AKT1/STAT3/MAPK1",5
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","3/44","37/2914",0.0174570423782922,0.0556456658136809,0.0349126532775778,"EP300/HDAC1/GSK3B",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"MAPK3/MAPK1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"CTNNB1/PAX6",2
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"CTNNB1/GSK3B",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"CTNNB1/GSK3B",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"CTNNB1/GSK3B",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"CTNNB1/GSK3B",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"CTNNB1/GSK3B",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"CTNNB1/GSK3B",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/44","14/2914",0.0180737762467223,0.0556456658136809,0.0349126532775778,"SMAD2/SMAD3",2
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/44","103/2914",0.0181812571470443,0.0556456658136809,0.0349126532775778,"CTNNB1/MAPK3/AKT1/STAT3/MAPK1",5
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","3/44","38/2914",0.0187564162812451,0.0570601820604142,0.0358001350707341,"PCGF2/UBE2I/PIAS1",3
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/44","39/2914",0.0201084247668453,0.0608069132171071,0.038150872075767,"RB1/CDK2/AKT1",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/44","15/2914",0.0206561865463516,0.0613610247406327,0.0384985272473797,"SMAD2/SMAD3",2
"R-HSA-69541","R-HSA-69541","Stabilization of p53","2/44","15/2914",0.0206561865463516,0.0613610247406327,0.0384985272473797,"ATM/CHEK2",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/44","15/2914",0.0206561865463516,0.0613610247406327,0.0384985272473797,"SMAD3/STAT3",2
"R-HSA-69242","R-HSA-69242","S Phase","4/44","71/2914",0.0210831808384381,0.0622631948737498,0.0390645579093251,"RB1/CDK2/AKT1/GSK3B",4
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/44","40/2914",0.0215131917692373,0.0627986233726292,0.0394004911624,"RB1/CDK2/AKT1",3
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/44","40/2914",0.0215131917692373,0.0627986233726292,0.0394004911624,"SMAD3/AKT1/EP300",3
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","3/44","41/2914",0.0229707989617717,0.0659687114751055,0.0413894364856837,"CREB1/PPARG/HDAC1",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","10/44","332/2914",0.023008320441408,0.0659687114751055,0.0413894364856837,"SMAD3/MAPK3/MAPK14/CREB1/RPS6KA5/STX1A/AKT1/STAT3/MAPK1/DUSP7",10
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/44","16/2914",0.0233829690179087,0.0659687114751055,0.0413894364856837,"MAPK3/MAPK1",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/44","16/2914",0.0233829690179087,0.0659687114751055,0.0413894364856837,"CTNNB1/GSK3B",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/44","16/2914",0.0233829690179087,0.0659687114751055,0.0413894364856837,"UBE2I/PIAS1",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/44","16/2914",0.0233829690179087,0.0659687114751055,0.0413894364856837,"CSNK2A1/CSNK2A2",2
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","3/44","42/2914",0.0244812872955919,0.0686836115792996,0.0430927922571531,"CTNNB1/STX1A/PAX6",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","9/44","289/2914",0.025719068831196,0.0717576229820661,0.045021458087758,"CSNK2A1/VDR/CSNK2A2/PPARG/UBE2I/STK11/STX1A/AKT1/EP300",9
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/44","17/2914",0.026249383828589,0.0720431458338991,0.0452005980114718,"UBE2I/PIAS1",2
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","2/44","17/2914",0.026249383828589,0.0720431458338991,0.0452005980114718,"PCGF2/UBE2I",2
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/44","17/2914",0.026249383828589,0.0720431458338991,0.0452005980114718,"SMAD3/EP300",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","4/44","77/2914",0.0275095282042045,0.0750935769898554,0.0471144693568452,"RB1/CDK2/AKT1/HDAC1",4
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/44","44/2914",0.027660876539669,0.0751007669491012,0.0471189804099624,"MAPK3/MAPK14/MAPK1",3
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","11/44","393/2914",0.027910762958967,0.0753739855309003,0.0472904005102678,"SMAD2/SMAD3/VDR/PCGF2/PPARG/UBE2I/EP300/PIAS1/HDAC1/CSNK1D/PRKDC",11
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","2/44","18/2914",0.0292507956950967,0.0785726160958715,0.049297253663069,"PRKAA1/STK11",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/44","46/2914",0.031051528700149,0.0829683703363768,0.0520551943121405,"NR0B2/VDR/PPARG",3
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","2/44","19/2914",0.0323826719220678,0.0851731735450219,0.0534385101345526,"CDK2/HDAC1",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/44","19/2914",0.0323826719220678,0.0851731735450219,0.0534385101345526,"RPS6KA5/EP300",2
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","2/44","19/2914",0.0323826719220678,0.0851731735450219,0.0534385101345526,"CSNK2A1/CSNK2A2",2
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","3/44","48/2914",0.034652253487295,0.0906704042025076,0.0568875282229386,"CDK2/UBE2I/ATM",3
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/44","20/2914",0.0356405804738892,0.0922999648169951,0.0579099310264002,"MAPK3/HDAC1",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/44","20/2914",0.0356405804738892,0.0922999648169951,0.0579099310264002,"MAPK3/HDAC1",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/44","49/2914",0.0365309412184932,0.0941230883435667,0.0590537771577146,"EP300/HDAC1/MYB",3
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/44","52/2914",0.0424774163344386,0.107356077381365,0.0673562882580317,"CREB1/EP300/CSNK1D",3
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/44","22/2914",0.0425172583688572,0.107356077381365,0.0673562882580317,"SMAD2/SMAD3",2
"R-HSA-525793","R-HSA-525793","Myogenesis","2/44","22/2914",0.0425172583688572,0.107356077381365,0.0673562882580317,"CTNNB1/MAPK14",2
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","2/44","22/2914",0.0425172583688572,0.107356077381365,0.0673562882580317,"CREB1/HDAC1",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","3/44","53/2914",0.0445620803618218,0.111959455635423,0.0702444943121673,"CSNK2A1/PRKAA1/CSNK2A2",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/44","92/2914",0.0482776354538923,0.120694088634731,0.0757246913581115,"MAPK3/EGFR/AKT1/MAPK1",4
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","3/44","55/2914",0.0488831594469083,0.121605889264476,0.0762967642910003,"UBE2I/EP300/PIAS1",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","2/44","24/2914",0.0498473150727557,0.123396539763439,0.0774202365165091,"EGFR/AKT1",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/44","56/2914",0.0511188213620751,0.125926852623649,0.0790077803850301,"CSNK2A1/CSNK2A2/CSNK1D",3
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/44","25/2914",0.0536722969310172,0.129069095000779,0.0809792550187276,"CREB1/CAMKK2",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/44","25/2914",0.0536722969310172,0.129069095000779,0.0809792550187276,"CREB1/CAMKK2",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/44","25/2914",0.0536722969310172,0.129069095000779,0.0809792550187276,"MAPK3/MAPK1",2
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","2/44","25/2914",0.0536722969310172,0.129069095000779,0.0809792550187276,"CTNNB1/AKT1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/44","25/2914",0.0536722969310172,0.129069095000779,0.0809792550187276,"MAPK3/MAPK1",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","4/44","97/2914",0.0567184861979976,0.135748035687151,0.0851696899256536,"EGFR/CREB1/AKT1/GSK3B",4
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","3/44","59/2914",0.0581213177937003,0.138449365499145,0.0868645315586087,"CDK2/UBE2I/ATM",3
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","4/44","99/2914",0.0603065524314214,0.142980323839755,0.0897073006269228,"MAPK3/EGFR/AKT1/MAPK1",4
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/44","27/2914",0.0616228321291695,0.144742001047584,0.0908125947166708,"MAPK3/MAPK1",2
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","2/44","27/2914",0.0616228321291695,0.144742001047584,0.0908125947166708,"ATM/PRKDC",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","3/44","61/2914",0.0630313562892053,0.147364976509485,0.0924582760382593,"CSNK2A1/PRKAA1/CSNK2A2",3
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/44","62/2914",0.0655574257124781,0.15090528083456,0.0946794987622771,"CDK2/ATM/CHEK2",3
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/44","28/2914",0.0657409144229765,0.15090528083456,0.0946794987622771,"SMAD2/SMAD3",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/44","28/2914",0.0657409144229765,0.15090528083456,0.0946794987622771,"MAPK3/MAPK1",2
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","2/44","28/2914",0.0657409144229765,0.15090528083456,0.0946794987622771,"VDR/UBE2I",2
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/44","63/2914",0.0681301725055288,0.154980797816631,0.0972365193179903,"SMAD2/SMAD3/HDAC1",3
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","3/44","63/2914",0.0681301725055288,0.154980797816631,0.0972365193179903,"CDK2/UBE2I/ATM",3
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/44","29/2914",0.0699493681230924,0.158405519740635,0.0993852244751041,"CREB1/EP300",2
"R-HSA-109582","R-HSA-109582","Hemostasis","8/44","298/2914",0.073876149796266,0.16230977360853,0.10183479282161,"MAPK3/MAPK14/CDK5/CDK2/AKT1/HDAC1/MAPK1/MYB",8
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/44","30/2914",0.0742446687199413,0.16230977360853,0.10183479282161,"CSNK2A1/CSNK2A2",2
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/44","30/2914",0.0742446687199413,0.16230977360853,0.10183479282161,"CREB1/CAMKK2",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/44","30/2914",0.0742446687199413,0.16230977360853,0.10183479282161,"MAPK3/MAPK1",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/44","30/2914",0.0742446687199413,0.16230977360853,0.10183479282161,"CTNNB1/GSK3B",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/44","30/2914",0.0742446687199413,0.16230977360853,0.10183479282161,"MAPK3/MAPK1",2
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","2/44","30/2914",0.0742446687199413,0.16230977360853,0.10183479282161,"UBE2I/PIAS1",2
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","2/44","30/2914",0.0742446687199413,0.16230977360853,0.10183479282161,"CDK2/EP300",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","3/44","66/2914",0.0761230395079781,0.165698857549694,0.10396113834801,"CDK2/EP300/CSNK1D",3
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/44","31/2914",0.0786233732118747,0.169678647316225,0.106458098680946,"MAPK14/AKT1",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/44","31/2914",0.0786233732118747,0.169678647316225,0.106458098680946,"CTNNB1/GSK3B",2
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","3/44","68/2914",0.0816747939220843,0.175513918853841,0.110119207034927,"CDK2/EP300/CSNK1D",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/44","32/2914",0.0830821185386069,0.177031518405048,0.111071364335424,"MAPK3/MAPK1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/44","32/2914",0.0830821185386069,0.177031518405048,0.111071364335424,"MAPK3/MAPK1",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/44","34/2914",0.0922266699519825,0.195691043385509,0.122778538945364,"MAPK3/MAPK1",2
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/44","35/2914",0.0969061359025146,0.204759826906987,0.128468385406989,"PRKAA1/AKT1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/44","37/2914",0.106464154730561,0.223088788958229,0.139968161493334,"MAPK3/MAPK1",2
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","2/44","37/2914",0.106464154730561,0.223088788958229,0.139968161493334,"EGFR/EP300",2
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/44","38/2914",0.111336806866634,0.230430686342828,0.144574542134843,"MAPK14/CREB1",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/44","38/2914",0.111336806866634,0.230430686342828,0.144574542134843,"CDK5/GSK3B",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/44","38/2914",0.111336806866634,0.230430686342828,0.144574542134843,"MAPK3/MAPK1",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/44","80/2914",0.118440748746708,0.244132971906479,0.153171494619803,"MAPK14/CREB1/CSNK1D",3
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/44","40/2914",0.121255169658376,0.246910728538226,0.154914287212102,"EP300/HDAC1",2
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","2/44","40/2914",0.121255169658376,0.246910728538226,0.154914287212102,"PPARG/EP300",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/44","40/2914",0.121255169658376,0.246910728538226,0.154914287212102,"CTNNB1/TCF7",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/44","41/2914",0.126295393796664,0.256141260511306,0.160705616287448,"MAPK3/MAPK1",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","4/44","130/2914",0.130524454215813,0.2612203939231,0.163892315937161,"CTNNB1/MAPK3/MAPK14/MAPK1",4
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/44","42/2914",0.131386099121717,0.2612203939231,0.163892315937161,"MAPK3/MAPK1",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/44","42/2914",0.131386099121717,0.2612203939231,0.163892315937161,"MAPK3/MAPK1",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/44","42/2914",0.131386099121717,0.2612203939231,0.163892315937161,"MAPK3/MAPK1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/44","42/2914",0.131386099121717,0.2612203939231,0.163892315937161,"MAPK3/MAPK1",2
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","3/44","85/2914",0.135330070607151,0.268006610418083,0.168150056770908,"CTNNB1/MAPK14/AKT1",3
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/44","43/2914",0.136524705981353,0.268025814303603,0.168162105482824,"MAPK3/MAPK1",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/44","86/2914",0.13880637480116,0.268025814303603,0.168162105482824,"SMAD2/SMAD3/HDAC1",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"MAPK3",1
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"RB1",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"UBE2I",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"HDAC1",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"UBE2I",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"AKT1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"STAT3",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/44","10/2914",0.141341551953326,0.268025814303603,0.168162105482824,"EP300",1
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","2/44","44/2914",0.141708697859529,0.268025814303603,0.168162105482824,"EGFR/AKT1",2
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","2/44","46/2914",0.152203078831241,0.269714608517768,0.169221672045541,"UBE2I/PIAS1",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/44","46/2914",0.152203078831241,0.269714608517768,0.169221672045541,"MAPK3/MAPK1",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/44","46/2914",0.152203078831241,0.269714608517768,0.169221672045541,"ATM/CHEK2",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"STAT3",1
"R-HSA-112310","R-HSA-112310","Neurotransmitter release cycle","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"STX1A",1
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"RB1",1
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"AKT1",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"HDAC1",1
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"PRKDC",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"ATM",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"ATM",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"CDK2",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"CHEK2",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"CHEK2",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"CHEK2",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"CHEK2",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"GSK3B",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"EGFR",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"STAT3",1
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","1/44","11/2914",0.154351528438881,0.269714608517768,0.169221672045541,"AKT1",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/44","47/2914",0.157508739464597,0.274282460102143,0.172087588307962,"PPARG/EP300",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","3/44","92/2914",0.160294002770598,0.278173441234199,0.174528829205823,"CTNNB1/MAPK14/AKT1",3
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/44","48/2914",0.162850325811436,0.27851857411012,0.174745369061274,"PPARG/EP300",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"STAT3",1
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"CSNK1D",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"EP300",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"CREB1",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"CSNK1D",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"CDK2",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"CSNK1D",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"CSNK1D",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"HDAC1",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/44","12/2914",0.167168797728819,0.27851857411012,0.174745369061274,"HDAC1",1
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/44","49/2914",0.168225618772838,0.27851857411012,0.174745369061274,"MAPK3/MAPK1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/44","50/2914",0.173632455229148,0.27851857411012,0.174745369061274,"MAPK3/MAPK1",2
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/44","51/2914",0.179068726919844,0.27851857411012,0.174745369061274,"EP300/HDAC1",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/44","51/2914",0.179068726919844,0.27851857411012,0.174745369061274,"EP300/HDAC1",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/44","51/2914",0.179068726919844,0.27851857411012,0.174745369061274,"EP300/HDAC1",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/44","51/2914",0.179068726919844,0.27851857411012,0.174745369061274,"EP300/HDAC1",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/44","51/2914",0.179068726919844,0.27851857411012,0.174745369061274,"EP300/HDAC1",2
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"CREB1",1
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"EP300",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"MAPK14",1
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"EGFR",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"UBE2I",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"GSK3B",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"GSK3B",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"GSK3B",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"GSK3B",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"GSK3B",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"GSK3B",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"EP300",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"EGFR",1
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"AKT1",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/44","13/2914",0.179796148831483,0.27851857411012,0.174745369061274,"EP300",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/44","52/2914",0.18453237934326,0.284112352342519,0.178254962074202,"MAPK3/MAPK1",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/44","52/2914",0.18453237934326,0.284112352342519,0.178254962074202,"MAPK3/MAPK1",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","9/44","428/2914",0.187355128627461,0.287581580416011,0.180431590839436,"CTNNB1/MAPK3/MAPK14/CREB1/RPS6KA5/EP300/MAPK1/DUSP7/PRKDC",9
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"EGFR",1
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"EGFR",1
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"EGFR",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"ATM",1
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"EGFR",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"PIAS1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/44","14/2914",0.192236331338004,0.288069279898195,0.180737578424923,"EP300",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/44","153/2914",0.197656851976837,0.293376387110282,0.184067311141625,"MAPK3/MAPK14/AKT1/MAPK1",4
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/44","55/2914",0.201067859815051,0.293376387110282,0.184067311141625,"STK11/STX1A",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/44","55/2914",0.201067859815051,0.293376387110282,0.184067311141625,"MAPK3/MAPK1",2
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"AKT1",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"HDAC1",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"MAPK14",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"ATM",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"ATM",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"ATM",1
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"EP300",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"HDAC1",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"CDK5",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"CDK5",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"CTNNB1",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/44","15/2914",0.204492055965979,0.293376387110282,0.184067311141625,"AKT1",1
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"EGFR",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"CDK2",1
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"EGFR",1
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"EGFR",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"HDAC1",1
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"AKT1",1
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"EGFR",1
"R-HSA-6794361","R-HSA-6794361","Neurexins and neuroligins","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"STX1A",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/44","16/2914",0.21656599509585,0.302952430812754,0.190075417768919,"EP300",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","3/44","109/2914",0.225939068703437,0.313459422239659,0.196667610409874,"EP300/HDAC1/ASH2L",3
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","3/44","109/2914",0.225939068703437,0.313459422239659,0.196667610409874,"EP300/HDAC1/ASH2L",3
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","3/44","109/2914",0.225939068703437,0.313459422239659,0.196667610409874,"MAPK14/AKT1/CSNK1D",3
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/44","17/2914",0.228460783300054,0.31351275969165,0.196701074866465,"EGFR",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/44","17/2914",0.228460783300054,0.31351275969165,0.196701074866465,"MAPK14",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/44","17/2914",0.228460783300054,0.31351275969165,0.196701074866465,"HDAC1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/44","17/2914",0.228460783300054,0.31351275969165,0.196701074866465,"CDK2",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","4/44","165/2914",0.23636717288374,0.323483529285336,0.202956836508361,"MAPK3/EGFR/CREB1/MAPK1",4
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","1/44","18/2914",0.240179017865051,0.323549034636237,0.202997935227738,"STX1A",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/44","18/2914",0.240179017865051,0.323549034636237,0.202997935227738,"GSK3B",1
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/44","18/2914",0.240179017865051,0.323549034636237,0.202997935227738,"CDK2",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/44","18/2914",0.240179017865051,0.323549034636237,0.202997935227738,"PCGF2",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/44","18/2914",0.240179017865051,0.323549034636237,0.202997935227738,"EP300",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","2/44","62/2914",0.24025918413582,0.323549034636237,0.202997935227738,"MAPK3/MAPK1",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","3/44","114/2914",0.246234329522882,0.330713660662381,0.20749309402684,"CDK2/ATM/CHEK2",3
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/44","64/2914",0.251552877583204,0.331042307160666,0.207699290162294,"EP300/HDAC1",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/44","19/2914",0.251723259306328,0.331042307160666,0.207699290162294,"EP300",1
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","1/44","19/2914",0.251723259306328,0.331042307160666,0.207699290162294,"AKT1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/44","19/2914",0.251723259306328,0.331042307160666,0.207699290162294,"CTNNB1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/44","19/2914",0.251723259306328,0.331042307160666,0.207699290162294,"GSK3B",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/44","19/2914",0.251723259306328,0.331042307160666,0.207699290162294,"HDAC1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/44","19/2914",0.251723259306328,0.331042307160666,0.207699290162294,"EP300",1
"R-HSA-9609507","R-HSA-9609507","Protein localization","1/44","19/2914",0.251723259306328,0.331042307160666,0.207699290162294,"STX1A",1
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/44","20/2914",0.263096031876457,0.342431690973223,0.214845104706493,"MAPK14",1
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","1/44","20/2914",0.263096031876457,0.342431690973223,0.214845104706493,"CSNK1D",1
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/44","20/2914",0.263096031876457,0.342431690973223,0.214845104706493,"STX1A",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/44","20/2914",0.263096031876457,0.342431690973223,0.214845104706493,"EGFR",1
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/44","21/2914",0.27429982406631,0.352471784105564,0.221144360637363,"CTNNB1",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/44","21/2914",0.27429982406631,0.352471784105564,0.221144360637363,"AKT1",1
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","1/44","21/2914",0.27429982406631,0.352471784105564,0.221144360637363,"AKT1",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/44","21/2914",0.27429982406631,0.352471784105564,0.221144360637363,"MAPK14",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/44","21/2914",0.27429982406631,0.352471784105564,0.221144360637363,"UBE2I",1
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"EGFR",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"STAT3",1
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"EGFR",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"CDK5",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"CDK2",1
"R-HSA-6794362","R-HSA-6794362","Protein-protein interactions at synapses","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"STX1A",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"PRKDC",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/44","22/2914",0.285337089099522,0.359339725673961,0.225453376608363,"EP300",1
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","3/44","124/2914",0.287653951777151,0.361356332456371,0.226718616090396,"SMAD2/SMAD3/EP300",3
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","1/44","23/2914",0.296210245420276,0.365600329899108,0.229381342990373,"EP300",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/44","23/2914",0.296210245420276,0.365600329899108,0.229381342990373,"MAPK14",1
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","1/44","23/2914",0.296210245420276,0.365600329899108,0.229381342990373,"ATM",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/44","23/2914",0.296210245420276,0.365600329899108,0.229381342990373,"ATM",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/44","23/2914",0.296210245420276,0.365600329899108,0.229381342990373,"STAT3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/44","23/2914",0.296210245420276,0.365600329899108,0.229381342990373,"CDK2",1
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","1/44","23/2914",0.296210245420276,0.365600329899108,0.229381342990373,"CSNK1D",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/44","72/2914",0.296824030215117,0.365600329899108,0.229381342990373,"RPS6KA5/EP300",2
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/44","24/2914",0.306921677174516,0.374385137616257,0.234893020161529,"EP300",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/44","24/2914",0.306921677174516,0.374385137616257,0.234893020161529,"STAT3",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/44","24/2914",0.306921677174516,0.374385137616257,0.234893020161529,"ATM",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/44","24/2914",0.306921677174516,0.374385137616257,0.234893020161529,"STAT3",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/44","25/2914",0.317473734684662,0.381724371466082,0.239497729674394,"AKT1",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/44","25/2914",0.317473734684662,0.381724371466082,0.239497729674394,"CSNK1D",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/44","25/2914",0.317473734684662,0.381724371466082,0.239497729674394,"CSNK1D",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/44","25/2914",0.317473734684662,0.381724371466082,0.239497729674394,"CDK5",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/44","25/2914",0.317473734684662,0.381724371466082,0.239497729674394,"AKT1",1
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","1/44","25/2914",0.317473734684662,0.381724371466082,0.239497729674394,"AKT1",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","2/44","76/2914",0.31937669032908,0.383100305501628,0.240361004598208,"CTNNB1/TCF7",2
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","1/44","26/2914",0.327868734917917,0.386854465265299,0.242716402386358,"AKT1",1
"R-HSA-182971","R-HSA-182971","EGFR downregulation","1/44","26/2914",0.327868734917917,0.386854465265299,0.242716402386358,"EGFR",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/44","26/2914",0.327868734917917,0.386854465265299,0.242716402386358,"HDAC1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/44","26/2914",0.327868734917917,0.386854465265299,0.242716402386358,"CSNK1D",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/44","26/2914",0.327868734917917,0.386854465265299,0.242716402386358,"CTNNB1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/44","26/2914",0.327868734917917,0.386854465265299,0.242716402386358,"CSNK1D",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/44","26/2914",0.327868734917917,0.386854465265299,0.242716402386358,"GSK3B",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/44","27/2914",0.338108961948254,0.39433031358861,0.247406825200983,"CSNK1D",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/44","27/2914",0.338108961948254,0.39433031358861,0.247406825200983,"CSNK1D",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/44","27/2914",0.338108961948254,0.39433031358861,0.247406825200983,"CDK2",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/44","27/2914",0.338108961948254,0.39433031358861,0.247406825200983,"PRKDC",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/44","27/2914",0.338108961948254,0.39433031358861,0.247406825200983,"MYB",1
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","2/44","80/2914",0.341780245326614,0.397693603433041,0.249516987250329,"SMAD2/SMAD3",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/44","28/2914",0.348196667412153,0.402378299869879,0.252456213154421,"CSNK1D",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/44","28/2914",0.348196667412153,0.402378299869879,0.252456213154421,"EP300",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/44","28/2914",0.348196667412153,0.402378299869879,0.252456213154421,"EP300",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/44","82/2914",0.352906999442532,0.406890490224837,0.255287206998803,"SMAD3/STAT3",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","1/44","29/2914",0.358134070958191,0.410108176494073,0.257306015893103,"AKT1",1
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/44","29/2914",0.358134070958191,0.410108176494073,0.257306015893103,"STAT3",1
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","1/44","29/2914",0.358134070958191,0.410108176494073,0.257306015893103,"EP300",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/44","30/2914",0.367923360690544,0.420364925675848,0.263741204019657,"ATM",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","3/44","144/2914",0.371803250847558,0.423838920266404,0.265920823345883,"EGFR/AKT1/CSNK1D",3
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/44","31/2914",0.3775666936065,0.426557450271325,0.267626456553765,"AKT1",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/44","31/2914",0.3775666936065,0.426557450271325,0.267626456553765,"ASH2L",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/44","31/2914",0.3775666936065,0.426557450271325,0.267626456553765,"AKT1",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/44","31/2914",0.3775666936065,0.426557450271325,0.267626456553765,"STAT3",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/44","87/2914",0.38045072387485,0.428856284724998,0.26906876852991,"MAPK3/MAPK1",2
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/44","32/2914",0.387066196028045,0.43341115076311,0.27192653752933,"CREB1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/44","32/2914",0.387066196028045,0.43341115076311,0.27192653752933,"STAT3",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/44","32/2914",0.387066196028045,0.43341115076311,0.27192653752933,"EP300",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/44","33/2914",0.396423964027617,0.439022153144619,0.275446937147536,"MAPK14",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/44","33/2914",0.396423964027617,0.439022153144619,0.275446937147536,"ATM",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/44","33/2914",0.396423964027617,0.439022153144619,0.275446937147536,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/44","33/2914",0.396423964027617,0.439022153144619,0.275446937147536,"CDK2",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/44","33/2914",0.396423964027617,0.439022153144619,0.275446937147536,"AKT1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/44","34/2914",0.40564206384809,0.444358443044003,0.278794979377269,"MAPK3",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/44","34/2914",0.40564206384809,0.444358443044003,0.278794979377269,"CDK2",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/44","34/2914",0.40564206384809,0.444358443044003,0.278794979377269,"EP300",1
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","1/44","34/2914",0.40564206384809,0.444358443044003,0.278794979377269,"CSNK1D",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/44","34/2914",0.40564206384809,0.444358443044003,0.278794979377269,"ATM",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/44","35/2914",0.414722532317078,0.450397588860483,0.282584000514862,"MAPK3",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/44","35/2914",0.414722532317078,0.450397588860483,0.282584000514862,"MAPK14",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/44","35/2914",0.414722532317078,0.450397588860483,0.282584000514862,"CTNNB1",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/44","35/2914",0.414722532317078,0.450397588860483,0.282584000514862,"GSK3B",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","4/44","217/2914",0.417150919310179,0.452062691527125,0.283628702761156,"CREB1/CDK5/CAMKK2/MAPK1",4
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","2/44","94/2914",0.418213529452739,0.452243752406067,0.283742302187027,"AKT1/STAT3",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/44","37/2914",0.432478577881311,0.466670260320645,0.292793639096434,"CSNK1D",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/44","97/2914",0.434065411956995,0.467383865753267,0.293241362359007,"MAPK3/PIAS1",2
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","3/44","160/2914",0.438223606291469,0.470857279100408,0.295420617007239,"EGFR/AKT1/CSNK1D",3
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/44","39/2914",0.449707822428193,0.482170807486704,0.302518839090146,"EP300",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","4/44","228/2914",0.455470721296541,0.486040947660634,0.30494700416019,"CTNNB1/MAPK3/MAPK14/MAPK1",4
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/44","40/2914",0.458129685319727,0.486040947660634,0.30494700416019,"CDK2",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/44","40/2914",0.458129685319727,0.486040947660634,0.30494700416019,"CDK2",1
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","1/44","40/2914",0.458129685319727,0.486040947660634,0.30494700416019,"RB1",1
"R-HSA-69236","R-HSA-69236","G1 Phase","1/44","40/2914",0.458129685319727,0.486040947660634,0.30494700416019,"RB1",1
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/44","41/2914",0.466425542607803,0.492771755265566,0.309169980896165,"STAT3",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/44","41/2914",0.466425542607803,0.492771755265566,0.309169980896165,"STAT3",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/44","42/2914",0.474597236351366,0.498277763736881,0.312624506273687,"MAPK14",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/44","42/2914",0.474597236351366,0.498277763736881,0.312624506273687,"CSNK1D",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/44","42/2914",0.474597236351366,0.498277763736881,0.312624506273687,"STAT3",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/44","44/2914",0.490575370323092,0.51186066531645,0.321146556040128,"EGFR",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/44","44/2914",0.490575370323092,0.51186066531645,0.321146556040128,"EGFR",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/44","44/2914",0.490575370323092,0.51186066531645,0.321146556040128,"CDK2",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","7/44","436/2914",0.494491897058769,0.514883315494182,0.323042997318914,"MAPK3/EGFR/CREB1/CDK5/AKT1/CAMKK2/MAPK1",7
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/44","45/2914",0.498385364645665,0.516806178944684,0.324249421286816,"STAT3",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/44","45/2914",0.498385364645665,0.516806178944684,0.324249421286816,"STX1A",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/44","47/2914",0.513655903566644,0.531549654305646,0.333499626776445,"PIAS1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/44","48/2914",0.521119852029521,0.538170808333145,0.337653805749404,"MAPK14",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/44","49/2914",0.528471815222368,0.544649523851625,0.341718617361832,"STAT3",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/44","51/2914",0.542846328971951,0.558324635704349,0.350298520785845,"CDK2",1
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","1/44","53/2914",0.556792298113512,0.570345051820129,0.357840251376465,"AKT1",1
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","1/44","53/2914",0.556792298113512,0.570345051820129,0.357840251376465,"EGFR",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/44","125/2914",0.570113990409532,0.581843871135259,0.365054726861309,"MAPK14/MAPK1",2
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/44","55/2914",0.5703222103207,0.581843871135259,0.365054726861309,"GSK3B",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/44","126/2914",0.574534706372696,0.584959731286717,0.36700964901991,"CTNNB1/STX1A",2
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/44","57/2914",0.583448197796615,0.59283971808308,0.371953632398139,"CTNNB1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/44","62/2914",0.614572520902568,0.623211090473487,0.391008938473204,"STAT3",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","7/44","486/2914",0.618217693907578,0.62565117319304,0.392539871039302,"MAPK3/EGFR/CREB1/CDK5/AKT1/CAMKK2/MAPK1",7
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/44","66/2914",0.637824827919371,0.642917241715134,0.403372776980209,"EP300",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","1/44","66/2914",0.637824827919371,0.642917241715134,0.403372776980209,"EGFR",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/44","72/2914",0.670154258517197,0.67415916444459,0.422974275138763,"EGFR",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/44","76/2914",0.69012181942821,0.692865842567089,0.434711034106709,"HDAC1",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/44","106/2914",0.806555835641842,0.808156144839544,0.507045335271918,"HDAC1",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","1/44","296/2914",0.991350045366123,0.991350045366123,0.621983040448573,"AKT1",1
